Department Directory


    Education/Credentials:

  • BS: Rose-Hulman Institute of Technology, 2004
  • Ph.D.: University of Cincinnati, 2010

Peer Reviewed Publications (in chronological order):

  • Koch, S. E., Tranter, M., Robbins, N., Luther, K., Singh, U., Jiang, M., Ren, X., Tee, T., Smith, L., Varma, P., Jones, W. K., & Rubinstein, J. (2013). Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model. . Journal of Cardiovascular Pharmacology and Therapeutics , 18 (3) , 280-9.
  • Koch, S. E., Gao, X., Haar, L., Jiang, M., Lasko, V. M., Robbins, N., Cai, W., Brokamp, C., Varma, P., Tranter, M., Liu, Y., Ren, X., Lorenz, J. N., Wang, H., Jones, W. K., & Rubinstein, J. (2012). Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation. . Journal of Molecular and Cellular Cardiology , 53 (1) , 134-44.
  • Robbins, N., Koch, S. E., Tranter, M., & Rubinstein, J. (2012). The history and future of probenecid. . Cardiovascular Toxicology , 12 (1) , 1-9.
  • Tranter, M., Liu, Y., He, S., Gulick, J., Ren, X., Robbins, J., Jones, W. K., & Reineke, T. M. (2012). In vivo delivery of nucleic acids via glycopolymer vehicles affords therapeutic infarct size reduction in vivo. . Molecular Therapy : the Journal of the American Society of Gene Therapy , 20 (3) , 601-8.
  • Tranter M, Liu Y, He S, Gulick J, Ren X, Robbins J, Jones WK, Reineke TM. (2012). Delivery of NF-κB oligodeoxynucleotide decoys via glycopolymer vehicles affords therapeutic infarct size reduction in vivo. . Molecular Therapy , 20 (3) , 601.
  • Tranter, M., Helsley, R. N., Paulding, W. R., McGuinness, M., Brokamp, C., Haar, L., Liu, Y., Ren, X., & Jones, W. K. (2011). Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation. . The Journal of Biological Chemistry , 286 (34) , 29828-37.
  • Wilhide, M. E., Tranter, M., Ren, X., Chen, J., Sartor, M. A., Medvedovic, M., & Jones, W. K. (2011). Identification of a NF-?B cardioprotective gene program: NF-?B regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion. . Journal of Molecular and Cellular Cardiology , 51 (1) , 82-9.
  • Tranter, M., Ren, X., Forde, T., Wilhide, M. E., Chen, J., Sartor, M. A., Medvedovic, M., & Jones, W. K. (2010). NF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning. . Journal of Molecular and Cellular Cardiology , 49 (4) , 664-72.
  • Kwon, O., Tranter, M., Jones, W. K., Sankovic, J. M., & Banerjee, R. K. (2009). Differential translocation of nuclear factor-kappaB in a cardiac muscle cell line under gravitational changes. . Journal of Biomechanical Engineering , 131 (6) , 064503.
  • Tranter, M., & Jones, W. K. (2008). Anti-inflammatory effects of HO-1 activity in vascular endothelial cells, commentary on "Carbon monoxide donors or heme oxygenase (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death". . Free Radical Biology & Medicine , 44 (3) , 261-3.
  • Tranter M and Jones WK. (2008). Anti-Inflammatory effects of HO-1 activity in vascular endothelial cells. . Free Radical Biology and Medicine. , 44 (3) , 261.
CARE/Crawley Building

More Information


For more information on the UC Department of Internal Medicine, please contact us at:

UC Department of Internal Medicine
231 Albert Sabin Way
Medical Sciences Building Room 6065
PO Box 670557
Cincinnati, OH 45267-0557

Phone: 513-558-4231
Fax: 513-558-0852
Email: ucintmed@uc.edu